MarginsXMarginsX
Home › Markets › Health Care › XBIT

XBiotech Inc. (XBIT)

XBIT trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$1.85
-5.37% on the day
Market cap
$56.4M
Micro cap
Revenue · 2023
$0
-100.0% on 2022
Net income · 2023
-$24.6M

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax), fiscal year ended 2023-12-31, https://www.sec.gov/Archives/edgar/data/1626878/000117184324001382/0001171843-24-001382-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2023-12-31.

Profile

FieldValue
TickerXBIT on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO year2015
SEC CIK0001626878
SEC industry codePharmaceutical Preparations
Incorporated inBC

Financials · 2023

LineValue
Revenue$0
Net income-$24.6M
Operating income-$37.5M
Net marginNeeds revenue and net income
Operating marginOperating income not reported
Revenue growth-100.0%
Cash$200.0M
Total assets$226.6M
P/E (computed)Net income was not positive
P/S (computed)Needs market cap and revenue

Warning signs

Cash runway
30.8 months
$105.0M cash at September 30, 2026
Share count, 1 year
0.0%
2025-11-12 to 2026-11-12 · +0.2% over 3 years
Going-concern doubt
No
10-Q filed November 12, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-12
Cash and burn$105.0M cash; operating cash flow -$10.2M a quarter.Report 2026-09-30
Shares outstanding30,487,731 (2026-11-12); 30,487,731 a year earlier; 30,436,964 three years earlier.Cover page 2026-11-12
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorWhitley Penn LLP, Austin, Texas, United StatesPCAOB Form AP 2026-03-15
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
Not filed-$4.5M-$4.5M$105.0MNo debt tagsNeeds four quarters10-Q 2026-11-12
Q2 2026
2026-06-30
Not filed-$6.7M-$4.5M$109.5MNo debt tagsNeeds four quarters10-Q 2026-08-13
Q1 2026
2026-03-31
Not filed-$5.5M-$9.0M$115.5MNo debt tagsNeeds four quarters10-Q 2026-05-14
Q4 2025
2025-12-31
Not filed-$26.9M-$23.0M$125.6MNo debt tagsNeeds four quarters10-K 2026-03-13
Q3 2025
2025-09-30
Not filed-$6.0M-$4.3M$147.4MNo debt tagsNeeds four quarters10-Q 2026-11-12
Q2 2025
2025-06-30
Not filed-$1.8M-$6.0M$152.9MNo debt tagsNeeds four quarters10-Q 2026-08-13
Q1 2025
2025-03-31
Not filed-$10.9M-$6.7M$155.9MNo debt tagsNeeds four quarters10-Q 2026-05-14
Q4 2024
2024-12-31
Not filed-$10.5M-$6.5M$172.7MNo debt tagsNeeds four quarters10-K 2026-03-13

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
FORM 424B5
424B52019-06-03
Latest annual report
FORM 10-K/A
10-K/A2026-04-29
Latest quarterly / interim
FORM 10-Q
10-Q2026-11-12
Latest current report
FORM 8-K
8-K2026-10-26
Latest proxy
FORM DEF 14A
DEF 14A2026-10-02

Source: SEC EDGAR submissions feed, 409 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+3.7%
1 month-9.3%
3 months-15.9%
Year to date-18.0%
1 year-26.0%
From 52-week high-27.7%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
TNXPTonix Pharmaceuticals Holding Corp.$2.88-4.32%$56.0M
BOLDBoundless Bio Inc.$2.41-3.60%$56.9M
SPROSpero Therapeutics Inc.$0.9464-5.35%$55.1M
FBIOFortress Biotech Inc.$1.71-9.04%$57.7M
VRCAVerrica Pharmaceuticals Inc.$3.20-10.11%$55.0M
CINGCingulate Inc.$3.75-12.79%$54.5M
INCRIntercure Ltd.$3.63-4.22%$54.5M
AZRAzora Therapeutics Inc.$3.81-6.85%$54.4M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier